6

KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Download PDF Report

Upload
vomien
View
217
Download
0

Embed Size (px)

Citation preview

Page 1: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 2: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 3: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 4: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 5: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Page 6: KM 454e-20150603103119 - npra.gov.my · Adalah saya merujuk kepada Arahan Bilangan 4 tahun 2015 oleh Pengarah Kanan Perkhidmatan Farmasi. ... co-administration with potent CYP3A4

Design of miscellaneous prodrugs of the potent Nωω ·

Design of miscellaneous prodrugs of the potent Nωω ·

Documents

ARTICLE Broad and potent neutralizing human antibodies to

ARTICLE Broad and potent neutralizing human antibodies to

Documents

1. BEùERİ TIBBİ ÜRÜNÜN ADI - pdf.ilacprospektusu.com · Saksagliptinin potent CYP3A4/5 indükleyicisi rifampisin ile birlikte uygulanması, saksagliptinin C maks ve EAA değerlerini

1. BEùERİ TIBBİ ÜRÜNÜN ADI - pdf.ilacprospektusu.com · Saksagliptinin potent CYP3A4/5 indükleyicisi rifampisin ile birlikte uygulanması, saksagliptinin C maks ve EAA değerlerini

Documents

Aerococcus urinae – A potent biofilm builder in endocarditis

Aerococcus urinae – A potent biofilm builder in endocarditis

Documents

Utjecaj polimorfizama CYP3A4/5 i CYP2D6 na serumske

Utjecaj polimorfizama CYP3A4/5 i CYP2D6 na serumske

Documents

CYP3A4 · 2020-07-15 · 폐경후질출혈 2019.05.07 cyp3a4 억제제: 트리암시놀론은 cyp3a4 기질이다. 케 토코나졸은 특정 코르티코스테로이드제의 대사를

CYP3A4 · 2020-07-15 · 폐경후질출혈 2019.05.07 cyp3a4 억제제: 트리암시놀론은 cyp3a4 기질이다. 케 토코나졸은 특정 코르티코스테로이드제의 대사를

Documents

Dithiocarbamates as Potent Inhibitors of Nuclear Factor KB

Dithiocarbamates as Potent Inhibitors of Nuclear Factor KB

Documents

PENGARUH POLIMORFISME GEN CYP3A4 DAN DURASI …erepository.uwks.ac.id/2980/1/Abstrak (upload).pdfsendiri di metabolisme oleh enzim CYP3A4, enzim ini aktifitasnya diatur oleh gen CYP3A4

PENGARUH POLIMORFISME GEN CYP3A4 DAN DURASI …erepository.uwks.ac.id/2980/1/Abstrak (upload).pdfsendiri di metabolisme oleh enzim CYP3A4, enzim ini aktifitasnya diatur oleh gen CYP3A4

Documents

13 most potent fermented foods for a healthy bellybetterbellyproject.com/assets/files/13_most_potent...13 Most Potent Fermented Foods for a Healthy belly by Summer Bock Introduction

13 most potent fermented foods for a healthy bellybetterbellyproject.com/assets/files/13_most_potent...13 Most Potent Fermented Foods for a Healthy belly by Summer Bock Introduction

Documents

CK2 acts as a potent negative regulator of receptor

CK2 acts as a potent negative regulator of receptor

Documents

ANEXA I REZUMATUL CARACTERISTICILOR PRODUSULUI · pasaj hepatic, mediată de enzima CYP3A4. Se recomandă precauţie la administrarea concomitentă cu inhibitori puternici ai CYP3A4

ANEXA I REZUMATUL CARACTERISTICILOR PRODUSULUI · pasaj hepatic, mediată de enzima CYP3A4. Se recomandă precauţie la administrarea concomitentă cu inhibitori puternici ai CYP3A4

Documents

l-Serine modified polyamidoamine dendrimer as a highly potent renal targeting drug … · L-Serine–modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier

l-Serine modified polyamidoamine dendrimer as a highly potent renal targeting drug … · L-Serine–modified polyamidoamine dendrimer as a highly potent renal targeting drug carrier

Documents

Facile green synthesis and potent antimicrobial efﬁcacy of

Facile green synthesis and potent antimicrobial efﬁcacy of

Documents

LAPORAN TAHUNAN ANNUAL REPORT - npra.gov.my fileLAPORAN TAHUNAN ANNUAL REPORT - npra.gov.my

LAPORAN TAHUNAN ANNUAL REPORT - npra.gov.my fileLAPORAN TAHUNAN ANNUAL REPORT - npra.gov.my

Documents

FARMAKOVIGJILENCAomi.al/.../materialet-e-trajnimit-te-farmakovigjilences.docx · Web viewKonsiderohet si makrolidi me i sigurt per terapi sebashku me agjent qe bllokojne CYP3A4. CYP3A4

FARMAKOVIGJILENCAomi.al/.../materialet-e-trajnimit-te-farmakovigjilences.docx · Web viewKonsiderohet si makrolidi me i sigurt per terapi sebashku me agjent qe bllokojne CYP3A4. CYP3A4

Documents

Intermittent dosing of RMC-4630, a potent, selective

Intermittent dosing of RMC-4630, a potent, selective

Documents

BILAGI PRODUKTRESUME - European Commission · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration af saxagliptin

BILAGI PRODUKTRESUME - European Commission · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration af saxagliptin

Documents

Rappresentazione del CITOCROMO CYP3A4, …...Rappresentazione del CITOCROMO CYP3A4, l'enzima maggior-mente coinvolto nella degradazione dei farmaci e nelle Interazio-ni farmacologiche

Rappresentazione del CITOCROMO CYP3A4, …...Rappresentazione del CITOCROMO CYP3A4, l'enzima maggior-mente coinvolto nella degradazione dei farmaci e nelle Interazio-ni farmacologiche

Documents

BILAGI PRODUKTRESUME - European Medicines Agency · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration

BILAGI PRODUKTRESUME - European Medicines Agency · Glykæmisk kontrol skal nøje vurderes, når saxagliptin anvendes samtidig med en potent CYP3A4-inducer. Samtidig administration

Documents

6 Potent Natural Antibiotics: No Prescription Required

6 Potent Natural Antibiotics: No Prescription Required

Health & Medicine

ANEXA I REZUMATUL CARACTERISTICILOR … · Administrare concomitentă cu inductori puternici ai CYP3A4/5 precum rifampicină, ... CYP3A4 şi/sau ai CYP3A5 poate reduce concentraţiileplasmatice

ANEXA I REZUMATUL CARACTERISTICILOR … · Administrare concomitentă cu inductori puternici ai CYP3A4/5 precum rifampicină, ... CYP3A4 şi/sau ai CYP3A5 poate reduce concentraţiileplasmatice

Documents

Catechins and procyanidins of ginkgo biloba show potent

Catechins and procyanidins of ginkgo biloba show potent

Documents

Lucrare de Licenta Valorificarea Bazei Materiale Si a Potent

Lucrare de Licenta Valorificarea Bazei Materiale Si a Potent

Documents

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of … · Translational Cancer Mechanisms and Therapy Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor

Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of … · Translational Cancer Mechanisms and Therapy Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor

Documents

Development of Potent and Selective Inhibitors of Aldo

Development of Potent and Selective Inhibitors of Aldo

Documents

ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …...Medicamentos quimioterapéuticos que son sustratos de CYP3A4 Netupitant es un inhibidor moderado de CYP3A4 y puede aumentar la exposición

ANEXO I FICHA TÉCNICA O RESUMEN DE LAS …...Medicamentos quimioterapéuticos que son sustratos de CYP3A4 Netupitant es un inhibidor moderado de CYP3A4 y puede aumentar la exposición

Documents

VEDLEGG I PREPARATOMTALE...samtidig bruk av CYP2D6- eller CYP3A4-hemmer vurderes på nytt. Samtidig administrering av CYP3A4- induktorer og Abilify Maintena skal unngås i mer enn

VEDLEGG I PREPARATOMTALE...samtidig bruk av CYP2D6- eller CYP3A4-hemmer vurderes på nytt. Samtidig administrering av CYP3A4- induktorer og Abilify Maintena skal unngås i mer enn

Documents

Highly potent and selective acylguanidine- type histamine H2

Highly potent and selective acylguanidine- type histamine H2

Documents

Design and synthesis of colchicine derivatives with potent in ...S1 ELECTRONIC SUPPORTING INFORMATION (ESI) Design and synthesis of colchicine derivatives with potent in vitro and

Design and synthesis of colchicine derivatives with potent in ...S1 ELECTRONIC SUPPORTING INFORMATION (ESI) Design and synthesis of colchicine derivatives with potent in vitro and

Documents

A Potent and Site-Selective Agonist of TRPA1

A Potent and Site-Selective Agonist of TRPA1

Documents